Literature DB >> 31958240

Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.

Ningxi Li1, Yan Chen2, Huimin Sun1, Tingwenli Huang1, Tianyu Chen1, Yichun Jiang1, Qian Yang1, Xiaoyan Yan1, Min Wu1.   

Abstract

Objective: A polymer-based nanoparticle was constructed to target sorafenib delivery to colorectal carcinoma cells and decrease the side effects of the drug.
Methods: Sorafenib-loaded nanoparticles (S-NPs) based on PEG-PLGA were prepared using a double emulsion solvent evaporation method. The properties of S-NPs were evaluated and then their effects on the viability of colorectal cancer cells and normal human cells were assessed. The mechanism of S-NP internalization was explored using cellular uptake assays and in vitro fluorescence confocal imaging. Acute toxicity of sorafenib on its own or within S-NPs was assessed in mice.
Results: S-NPs showed high drug loading and entrapment efficiencies, they did not cause extensive hemolysis, and they efficiently inhibited growth of colorectal cancer cell lines and human umbilical vein endothelial cells. S-NPs showed lower acute toxicity than the free drug.Conclusions: Loading sorafenib into nanoparticles can enhance its uptake by colorectal cancer cells and decrease its acute toxicity.

Entities:  

Keywords:  Sorafenib; acute toxicity; cellular uptake; colorectal cancer; nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 31958240     DOI: 10.1080/10837450.2020.1718704

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  The pH-triggered drug release and simultaneous carrier decomposition of effervescent SiO2-drug-Na2CO3 composite nanoparticles: to improve the antitumor activity of hydrophobic drugs.

Authors:  Tianyu Chen; Yichun Jiang; Changmao Wang; Zhengxue Cai; Hui Chen; Junliang Zhu; Pinrun Tao; Min Wu
Journal:  RSC Adv       Date:  2021-01-28       Impact factor: 3.361

Review 2.  Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer.

Authors:  Yu Guo; Min Wang; Yongbo Zou; Longhai Jin; Zeyun Zhao; Qi Liu; Shuang Wang; Jiannan Li
Journal:  J Nanobiotechnology       Date:  2022-08-11       Impact factor: 9.429

3.  PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment.

Authors:  Ana I Fraguas-Sánchez; Ana I Torres-Suárez; Marie Cohen; Florence Delie; Daniel Bastida-Ruiz; Lucile Yart; Cristina Martin-Sabroso; Ana Fernández-Carballido
Journal:  Pharmaceutics       Date:  2020-05-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.